storing reconstituted retatrutide Laboratory Reconstitution Bundle Retatrutide Dosing Guide for Researchers

What sets retatrutide apart is its triple agonist mechanism: it simultaneously activates the GLP-1, GIP, and glucagon receptorsthree critical regulators of energy balance and glucose metabolism

While they share a common mechanism of action, enhancing glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying, there are notable differences in their efficacy and usage in weight management

Our guide on Ozempic alternatives covers the full landscape of GLP-1 options available

Its first Phase 3 readout reported roughly 28.7% weight reduction at 12 mg over 68 weeks 5 a meaningful six-percentage-point ceiling advantage over tirzepatides SURMOUNT-1 peak of 22.5% over 72 weeks 13

Lee A, Morley J (1999) Classification of type 2 diabetes by clinical response to metformin-troglitazone combination and C-peptide criteria